WO2000032811A3 - Verfahren zur bestimmung des apolipoprotein-e-genotyps in einer menschlichen probe - Google Patents

Verfahren zur bestimmung des apolipoprotein-e-genotyps in einer menschlichen probe Download PDF

Info

Publication number
WO2000032811A3
WO2000032811A3 PCT/EP1999/009344 EP9909344W WO0032811A3 WO 2000032811 A3 WO2000032811 A3 WO 2000032811A3 EP 9909344 W EP9909344 W EP 9909344W WO 0032811 A3 WO0032811 A3 WO 0032811A3
Authority
WO
WIPO (PCT)
Prior art keywords
apolipoprotein
determining
primers
human sample
genotype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1999/009344
Other languages
English (en)
French (fr)
Other versions
WO2000032811A2 (de
Inventor
Michael Essrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU19690/00A priority Critical patent/AU1969000A/en
Publication of WO2000032811A2 publication Critical patent/WO2000032811A2/de
Publication of WO2000032811A3 publication Critical patent/WO2000032811A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Bestimmung des Apoliprprotein-E-Polymorphismus in einer menschlichen Probe durch PCR-Amplifikation einer ausgewählten Basensequenz und Nachweis der Apolipoprotein-E-Allele, wobei eine Multiplex-PCR mit 6 bis 7 verschiedenen spezifischen Primern verwendet wird und jeweils vier der Primer direkt an den mutationsspezifischen Stellen enden. Die Primer zeichnen sich aus unter anderem durch Basenmismatche an der dritten bis fünften Stelle vor dem 3'-Ende und dass zur Verbesserung der Amplifikationsselektivität die Mismatch-Stellen von ⊂ II und ⊂ III beziehungsweise von ⊂ V und ⊂ VI relativ zum 3'-Ende verschoben sind.
PCT/EP1999/009344 1998-12-01 1999-12-01 Verfahren zur bestimmung des apolipoprotein-e-genotyps in einer menschlichen probe Ceased WO2000032811A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU19690/00A AU1969000A (en) 1998-12-01 1999-12-01 Method for determining the apolipoprotein-e-genotype in a human sample

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855469.9 1998-12-01
DE19855469A DE19855469C2 (de) 1998-12-01 1998-12-01 Verfahren zur Bestimmung des Apolipoprotein-E-Genotyps in einer menschlichen Probe

Publications (2)

Publication Number Publication Date
WO2000032811A2 WO2000032811A2 (de) 2000-06-08
WO2000032811A3 true WO2000032811A3 (de) 2000-09-08

Family

ID=7889665

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/009344 Ceased WO2000032811A2 (de) 1998-12-01 1999-12-01 Verfahren zur bestimmung des apolipoprotein-e-genotyps in einer menschlichen probe

Country Status (3)

Country Link
AU (1) AU1969000A (de)
DE (1) DE19855469C2 (de)
WO (1) WO2000032811A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080037128A (ko) * 2006-10-25 2008-04-30 주식회사 씨젠 뉴클레오타이드 변이 검출 방법
WO2008143367A1 (en) * 2007-05-21 2008-11-27 Seegene, Inc. Haplotyping method by multiplex amplification

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013075A2 (en) * 1990-02-16 1991-09-05 Orion-Yhtymä Oy Method and reagent for determining specific nucleotide variations
JPH04320700A (ja) * 1991-04-17 1992-11-11 Nippon Shoji Kk アポリポプロテインｅ遺伝子タイプの検査方法及びその検査に好適なプライマー及びプローブ
DE4129653A1 (de) * 1991-09-06 1993-03-11 Boehringer Mannheim Gmbh Verfahren zum nachweis aehnlicher nukleinsaeuren
WO1995016791A1 (en) * 1993-12-15 1995-06-22 Mcgill University Apolipoprotein e polymorphism and alzheimer's disease
WO1996025517A1 (fr) * 1995-02-17 1996-08-22 Laboratoires Eurobio Procede de detection d'une mutation intervenant dans la maladie d'alzheimer et sequences nucleotidiques pour sa mise en ×uvre
JPH09206100A (ja) * 1996-01-31 1997-08-12 Terumo Corp 硬化性被嚢性腹膜炎の予測方法
DE19624562A1 (de) * 1996-06-20 1998-01-02 Thomas Dr Koehler Verfahren zur Bestimmung von Konzentrationsverhältnissen zweier sich um mindestens ein Nucleotid unterscheidender Nucleinsäuren und Testkit zur Durchführung des Verfahrens
WO1998020020A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. High density immobilization of nucleic acids
WO1998020166A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. Dna diagnostics based on mass spectrometry
WO1999004038A2 (en) * 1997-07-18 1999-01-28 Genset Biallelic markers for use in constructing a high density disequilibrium map of the human genome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780587A (en) * 1990-08-24 1998-07-14 President And Fellows Of Harvard College Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
JP3265577B2 (ja) * 1992-10-13 2002-03-11 デューク・ユニバーシティ アポリポ蛋白ｅの４型イソ型の測定法
WO1997048795A2 (en) * 1996-06-18 1997-12-24 Hybridon, Inc. Compositions and methods for treating specific gene expression-related diseases and disorders in humans

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013075A2 (en) * 1990-02-16 1991-09-05 Orion-Yhtymä Oy Method and reagent for determining specific nucleotide variations
JPH04320700A (ja) * 1991-04-17 1992-11-11 Nippon Shoji Kk アポリポプロテインｅ遺伝子タイプの検査方法及びその検査に好適なプライマー及びプローブ
DE4129653A1 (de) * 1991-09-06 1993-03-11 Boehringer Mannheim Gmbh Verfahren zum nachweis aehnlicher nukleinsaeuren
WO1995016791A1 (en) * 1993-12-15 1995-06-22 Mcgill University Apolipoprotein e polymorphism and alzheimer's disease
WO1996025517A1 (fr) * 1995-02-17 1996-08-22 Laboratoires Eurobio Procede de detection d'une mutation intervenant dans la maladie d'alzheimer et sequences nucleotidiques pour sa mise en ×uvre
JPH09206100A (ja) * 1996-01-31 1997-08-12 Terumo Corp 硬化性被嚢性腹膜炎の予測方法
DE19624562A1 (de) * 1996-06-20 1998-01-02 Thomas Dr Koehler Verfahren zur Bestimmung von Konzentrationsverhältnissen zweier sich um mindestens ein Nucleotid unterscheidender Nucleinsäuren und Testkit zur Durchführung des Verfahrens
WO1998020020A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. High density immobilization of nucleic acids
WO1998020166A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. Dna diagnostics based on mass spectrometry
WO1999004038A2 (en) * 1997-07-18 1999-01-28 Genset Biallelic markers for use in constructing a high density disequilibrium map of the human genome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 017, no. 158 (C - 1041) 29 March 1993 (1993-03-29) *
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 12 25 December 1997 (1997-12-25) *

Also Published As

Publication number Publication date
AU1969000A (en) 2000-06-19
WO2000032811A2 (de) 2000-06-08
DE19855469C2 (de) 2001-01-11
DE19855469A1 (de) 2000-06-15

Similar Documents

Publication Publication Date Title
ZA200007630B (en) Bitumen emulsions, method for obtaining them and compositions containing same.
AU7625998A (en) methods, kits and compositions for suppressing the binding of detectable probe s to non-target sequences in hybridization assays
AU4372199A (en) Electrochemical based assay processes, instrument and labels
AU5800499A (en) Integrated monolithic microfabricated electrospray and liquid chromatography system and method
EP1115389A4 (de) Antagonisten und agonisten der fructosamin oxidase
AU4680599A (en) Thermostable polymerase
AU3027699A (en) Nucleic acid analysis method
MXPA01002538A (es) Fertilizante foliar y metodo para utilizar el mismo.
WO2003040395A3 (en) Universal nucleotides for nucleic acid analysis
AU9125198A (en) Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
AU3691797A (en) Double-stranded dna with cohesive end(s), and method of shuffling dna using the same
EP0822256A3 (de) Modifizierte thermostabile DNA Polymerase und eine DNA Polymerasezusammensetzung zur Amplifikation von Nukleinsäuren
AU1913400A (en) Tapered shank rivet
AU2747597A (en) Method, compositions and kit for detection and identification of microorganisms
AU2001241674A1 (en) Variant galactose oxidase, nucleic acid encoding same, and methods of using same
AU3935599A (en) Method for amplifying at least a particular nucleotide sequence and primers used
AU2735797A (en) Detection probes, kits and assays
EP1312684A3 (de) Quantitative Multiplex-PCR mit grossem Dynamikbereich
ZA977601B (en) Adhesion enhancers for anionic bituminous emulsions.
WO2001016377A3 (en) Diagnostics and therapeutics for osteoporosis
EP0805561A3 (de) Verfahren zur Realisierung eines Direktumsetzempfängers mit einer Sechs-Tor-Schaltung
WO1999051744A3 (en) A interleukin-1 receptor antagonist and uses thereof
DE69704328D1 (de) Verfahren zur quantitativen Bestimmung von 1,5-Anhydroglucitol, sowie Reagenz zur quantitativen Bestimmung
AU1178100A (en) Novel g protein-coupled receptor protein, its dna and ligand thereof
WO2000032811A3 (de) Verfahren zur bestimmung des apolipoprotein-e-genotyps in einer menschlichen probe

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CN JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA CN JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase